In honor of March Madness, the Motley Fool's health-care team assembled their own bracket consisting of the 16 largest and best pharmaceutical and biotech stocks on the market. The series kicks off with a tough match up between Abbott (ABT 1.36%), the medical device giant that recently spun-off its pharmaceutical division, and diabetes giant Novo Nordisk (NVO 1.78%). To learn the bull and bear cases for each stock -- and to see which stock will move on to the Elite Eight -- watch the video below.
You might be more interested in March Madness -- but if you're a long-term investor, the first round of Market Madness will keep you on the edge of your seat.
About the Author
Max is the Technology, Biopharma & Health Care Bureau Chief at Fool.com. Prior to joining the Fool, he completed a PhD in chemistry at the University of Cambridge and an MBA at the College des Ingenieurs.
Follow @TMFMassimo